[Featured Stock] HK Innoen Soars on Success News of US COVID-19 Treatment
![[Featured Stock] HK Innoen Soars on Success News of US COVID-19 Treatment](http://www.asiae.co.kr/news/img_view.htm?img=2021072212303645301_1626924635.jpg)
[Asia Economy Reporter Ji Yeon-jin] HK Innoen is showing strength as it is grouped as a related stock following the news of the successful development of a COVID-19 treatment by the U.S. pharmaceutical company Merck (MSD) on the 5th.
As of 10:40 AM on the 5th, HK Innoen is trading at 63,600 won, up 21.14% (11,100 won) compared to the previous trading day.
HK Innoen signed a joint sales and distribution agreement with Merck in January for seven types of vaccines.
Hot Picks Today
There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- MBK: "Homeplus Rehabilitation Is a Public Procedure Under Court Supervision"
- Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- "Is It Possible to Look That Happy at Work? Of Course They're Smiling" SK hynix Employees' Expressions Go Viral
On the 1st (local time), Merck announced clinical results showing that its oral COVID-19 treatment under development, Molnupiravir, reduces hospitalization and mortality rates among COVID-19 patients.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
